Recent Finacing
Recent Raise
Curetis develops and commercializes the Unyvero molecular diagnostic platform and cartridge-based assays to rapidly detect pathogens and antibiotic-resistance markers for severe hospital-acquired infections within hours.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors